Greenwich LifeSciences, Inc.
Price Action
Technical Summary
CONSOLIDATINGGreenwich LifeSciences, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 78), indicating performance broadly in line with the market. Earnings contraction of 56% provides fundamental context to the price action. Investors should exercise caution due to high volatility (96% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $23.18 | -14.59% | BELOW |
| 50 SMA | $24.34 | -18.65% | BELOW |
| 100 SMA | $25.05 | -20.96% | BELOW |
| 150 SMA | $22.64 | -12.53% | BELOW |
| 200 SMA | $19.46 | +1.72% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is GLSI in an uptrend right now?
GLSI has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is GLSI overbought or oversold?
GLSI's RSI (14) is 30. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.
Is GLSI outperforming the market?
GLSI has a Relative Strength (RS) Rating of 78 out of 99. GLSI is performing about average compared to the market.
Where is GLSI in its 52-week range?
GLSI is trading at $19.80, which is 58% of its 52-week high ($34.10) and 46% above its 52-week low ($7.78).
How volatile is GLSI?
GLSI has a Beta of 2.82 and 52-week volatility of 96%. It's more volatile than the S&P 500 - expect bigger swings.